argenx SE (ARGX)

Today's Latest Price: $248.13 USD

6.25 (-2.46%)

Updated Oct 30 4:00pm

Add ARGX to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 384 in Biotech

See all "A" rated Strong Buy stocks

Argenx Se (ARGX) Price Targets From Analysts

Use the tables below to see what analysts covering Argenx Se think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
20 $300 $209 $261 $254.38 2.6%

ARGX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.3 13 2 5 0 0 20

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • The percent of analysts bearish on the stock of ARGX is less than nearly 100% of all US stocks.
  • ARGX has a greater average analyst price target than 98.46% of Pharmaceutical Products stocks.
  • The number of analysts covering the stock of ARGX is greater than 98.43% of stocks in the mid market cap category.
  • ARGX has a greater upside potential (average analyst target price relative to current price) than 6.94% of Pharmaceutical Products stocks.
  • The percentage of analysts bullish on the stock of ARGX is greater than 74.46% of stocks in the mid market cap category.
  • ARGX has a lower variance in analysts' estimates than 64.55% of Pharmaceutical Products stocks.
  • Argenx Se's change in bullishness amongst analysts is less than nearly 100% of all US stocks.

In the Pharmaceutical Products industry, JNJ, MRK and SRPT are the three stocks most similar to Argenx Se regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding ARGX using the data that counts. Try POWR Ratings for free.



Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.541 seconds.